Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
Open Access
- 28 July 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 16 (15) , 3860-3874
Abstract
Purpose: Deregulation of key cellular pathways is fundamental for the survival and expansion of neoplastic cells. In cancer, regulation of gene transcription can be mediated in a variety of ways. The purpose of this study was to assess the impact of gene dosage on gene expression patterns and the effect of other mechanisms on transcriptional levels, and to associate these genomic changes with clinicopathologic parameters. Experimental Design: We screened 97 invasive diploid breast tumors for DNA copy number alterations and changes in transcriptional levels using array comparative genomic hybridization and expression microarrays, respectively. Results: The integrative analysis identified an increase in the overall number of genetic alterations during tumor progression and 15 specific genomic regions with aberrant DNA copy numbers in at least 25% of the patient population, i.e., 1q22, 1q22-q23.1, 1q25.3, 1q32.1, 1q32.1-q32.2, 8q21.2-q21.3, 8q22.3, 8q24.3, and 16p11.2 were recurrently gained, whereas 11q25, 16q21, 16q23.3, and 17p12 were frequently lost (P < 0.01). An examination of the expression patterns of genes mapping within the detected genetic aberrations identified 47 unique genes and 1 Unigene cluster significantly correlated between the DNA and relative mRNA levels. In addition, more malignant tumors with normal gene dosage levels displayed a recurrent overexpression of UBE2C, S100A8, and CBX2, and downregulation of LOC389033, STC2, DNALI1, SCUBE2, NME5, SUSD3, SERPINA11, AZGP1, and PIP. Conclusions: Taken together, our findings suggest that the dysregulated genes identified here are critical for breast cancer initiation and progression, and could be used as novel therapeutic targets for drug development to complement classical clinicopathologic features. Clin Cancer Res; 16(15); 3860–74. ©2010 AACR.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancerBMC Cancer, 2009
- The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcomeInternational Journal of Cancer, 2009
- Gene expression variation to predict 10-year survival in lymph-node-negative breast cancerBMC Cancer, 2008
- Genes Involved in Differentiation, Stem Cell Renewal, and Tumorigenesis Are Modulated in Telomerase-Immortalized Human Urothelial CellsMolecular Cancer Research, 2008
- Detection of Copy Number Alterations in Metastatic Melanoma by a DNA FluorescenceIn situHybridization Probe Panel and Array Comparative Genomic Hybridization: A Southwest Oncology Group Study (S9431)Clinical Cancer Research, 2008
- UbcH10 is overexpressed in malignant breast carcinomasEuropean Journal of Cancer, 2007
- Novel patterns of genome rearrangement and their association with survival in breast cancerGenome Research, 2006
- Common fragile sites, extremely large genes, neural development and cancerCancer Letters, 2006
- A census of human cancer genesNature Reviews Cancer, 2004
- The Human Genome Browser at UCSCGenome Research, 2002